VoluMetrix discovered novel NIVAHF device for heart failure patients. It is an investigational device anticipated to monitor the venous waveform in heart failure patients. NIVAHF device is designed to provide a non-invasive solution for heart failure patients.
Presently, the clinical scores can be only found through invasive catheterization of the heart and vasculature. But with the introduction of NIVA vital monitoring technology the NIVA score can be obtained related to a pulmonary capillary wedge pressure, or PCWP.
NIVA is developed for the efficient hemodynamic assessment in three major ways including signal decoding, signal deconstruction which is usually done with mapping individual amplitudes within a patient's waveform, and capturing signal by using non-invasive wrist sensor.
NIVAHF device has granted Breakthrough Device by the U.S. Food and Drug Administration (FDA) for heart failure patients.